Common factors such as education, ethnicity, income, and marital status do not appear to be risk factors for the development of MDD. Instead, MDD often emerges subsequent to a significant ...

A University of Queensland-led team analyzed data for 204 countries and territories, to assess global access to adequate ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

“Major depressive disorder” is another name for clinical ... It can take time to find a treatment plan that works, but many people find that their symptoms respond well to a combination ...

Major depressive disorder (MDD) is a chronic and recurrent ... of such MDD patients remit following adequate antidepressant treatment, while most MDD patients suffer from significant core ...

A constant sense of hopelessness and despair is a sign you may have major ... disorder? Read how one woman found out why her mood worsened every winter. Is ketamine a treatment for depression?

Major depressive disorder is a debilitating ... firm bright light therapy as an efficient adjunctive treatment for non-seasonal depressive disorders,” the researchers wrote in their study ...

In the US, more than 7% of adults have experienced the symptoms of depression in a given year. While major depressive ... mental health disorder that requires treatment," says Andrea Wittenborn ...

Depression comes in forms ranging from major depression to dysthymia ... is a highly treatable disorder. As with many illnesses, the earlier treatment begins, the more effective it can be and ...

its Phase 3 pivotal program evaluating the efficacy and safety of CYB003 for the adjunctive treatment of Major Depressive Disorder (“MDD”). The program name, PARADIGM, represents the Company's ...